Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
92.06
80.93
77.76
64.15
43.20
28.26
25.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
92.06
80.93
77.76
64.15
43.20
28.26
25.77
Raw Material Cost
49.78
43.07
37.27
35.35
24.29
14.42
14.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.31
0.06
-0.05
0.22
-0.33
1.33
-0.67
Employee Cost
6.51
5.30
5.13
5.87
2.98
2.48
2.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
-0.01
0.00
-0.01
Selling and Distribution Expenses
10.78
9.35
5.37
3.81
3.00
1.27
2.11
Other Expenses
15.37
15.40
15.24
11.53
8.71
6.92
6.14
Total Expenditure (Excl Depreciation)
83.75
73.17
62.96
56.78
38.64
26.42
24.78
Operating Profit (PBDIT) excl Other Income
8.31
7.76
14.80
7.37
4.56
1.84
0.99
Other Income
9.22
7.74
1.05
1.21
1.22
0.79
1.96
Operating Profit (PBDIT)
17.53
15.50
15.85
8.58
5.78
2.63
2.95
Interest
2.97
2.04
3.01
2.42
0.25
0.47
0.32
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
14.56
13.46
12.84
6.16
5.53
2.16
2.63
Depreciation
1.71
1.46
1.53
1.71
1.14
0.98
0.89
Profit Before Tax
12.85
12.00
11.32
4.45
4.39
1.18
1.74
Tax
2.55
3.27
3.16
0.78
1.09
0.31
0.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.30
8.72
8.15
3.67
3.30
0.87
1.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.30
8.72
8.15
3.67
3.30
0.87
1.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.91
1.23
-0.06
0.84
0.04
-0.13
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.22
9.96
8.10
4.51
3.34
0.75
1.14
Equity Capital
17.48
16.08
16.08
15.58
15.56
15.48
15.43
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
117.88
0.00
0.00
Earnings per share (EPS)
6.42
6.06
4.93
2.89
2.15
0.48
0.74
Diluted Earnings per share
6.85
6.06
4.97
2.9
2.15
0.48
0.74
Operating Profit Margin (Excl OI)
9.03%
9.59%
19.03%
11.49%
10.56%
6.51%
3.84%
Gross Profit Margin
15.82%
16.63%
16.51%
9.6%
12.8%
7.64%
10.21%
PAT Margin
11.19%
10.77%
10.48%
5.72%
7.64%
3.08%
4.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 13.75% vs 4.08% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 12.65% vs 22.96% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 7.09% vs -47.57% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 45.59% vs -32.23% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Kilitch Drugs With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
92.06
253.13
-161.07
-63.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
92.06
253.13
-161.07
-63.63%
Raw Material Cost
49.78
173.39
-123.61
-71.29%
Purchase of Finished goods
0.00
0.67
-0.67
-100.00%
(Increase) / Decrease In Stocks
1.31
-12.64
13.95
110.36%
Employee Cost
6.51
32.19
-25.68
-79.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
10.78
0.00
10.78
Other Expenses
15.37
48.27
-32.90
-68.16%
Total Expenditure (Excl Depreciation)
83.75
241.88
-158.13
-65.38%
Operating Profit (PBDIT) excl Other Income
8.31
11.25
-2.94
-26.13%
Other Income
9.22
0.19
9.03
4,752.63%
Operating Profit (PBDIT)
17.53
11.44
6.09
53.23%
Interest
2.97
4.63
-1.66
-35.85%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
14.56
6.81
7.75
113.80%
Depreciation
1.71
8.54
-6.83
-79.98%
Profit Before Tax
12.85
-1.74
14.59
838.51%
Tax
2.55
0.74
1.81
244.59%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.30
-2.47
12.77
517.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.30
-2.47
12.77
517.00%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.91
0.00
0.91
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.22
-2.47
13.69
554.25%
Equity Capital
17.48
48.29
-30.81
-63.80%
Face Value
10.00
10.00
0.00
Reserves
0.00
452.80
-452.80
-100.00%
Earnings per share (EPS)
6.42
-0.51
6.93
1,358.82%
Diluted Earnings per share
6.85
-0.51
7.36
1,443.14%
Operating Profit Margin (Excl OI)
9.03%
4.44%
0.00
4.59%
Gross Profit Margin
15.82%
2.69%
0.00
13.13%
PAT Margin
11.19%
-0.98%
0.00
12.17%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 92.06 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 13.75% vs 4.08% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 11.22 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 12.65% vs 22.96% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.31 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 7.09% vs -47.57% in Sep 2024
Half Yearly - Interest
Interest 2.97 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 45.59% vs -32.23% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.03%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






